| # | Drug | Count |
|---|---|---|
| 0 | OLANZAPINE | 9 |
| 1 | QUETIAPINE | 9 |
| 2 | MIRTAZAPINE | 8 |
| 3 | TREPROSTINIL | 8 |
| 4 | AMBRISENTAN | 7 |
| 5 | CARBAMAZEPINE | 7 |
| 6 | GABAPENTIN | 7 |
| 7 | SILDENAFIL | 7 |
| 8 | SILDENAFIL CITRATE | 7 |
| 9 | TOLVAPTAN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIMOZIDE | 2 | 0.0041 |
| 1 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0011 |
| 2 | ILOPROST | 1 | 0.0011 |
| 3 | MARALIXIBAT CHLORIDE | 1 | 0.0010 |
| 4 | PSYLLIUM HUSK | 1 | 0.0007 |
| 5 | ZOLBETUXIMAB | 1 | 0.0007 |
| 6 | DOXYCYCLINE MONOHYDRATE | 1 | 0.0006 |
| 7 | DARUNAVIR ETHANOLATE AND COBICISTAT | 1 | 0.0006 |
| 8 | AMISULPRIDE | 3 | 0.0005 |
| 9 | TOLVAPTAN | 7 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Prostacycline [EPC] | 1 | 0.0011 |
| 2 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 3 | Vasopressin V2 Receptor Antagonist [EPC] | 7 | 0.0005 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 3 | 0.0004 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 6 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 5 | 0.0002 |
| 8 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 3 | 0.0002 |
| 9 | Bismuth [EPC] | 1 | 0.0002 |